COL1A2 and neoplasm: In this context, MSCMel were found to increase tumor collagen deposition and to modulate molecules primarily associated with collagen folding, such as COL1A2 and COL12A1, suggesting a potential link between these molecular changes and collagen-mediated tumor growth inhibition.